NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: Final report

Annals of Neurology

Volumn 57, Issue 6, 2005, Pages 843-847

  Herrlinger, Ulrich ^a,b   Küker, Wilhelm ^b   Uhl, Martin ^a   Blaicher, Hans Peter ^a   Karnath, Hans Otto ^a   Kanz, Lothar ^b   Bamberg, Michael ^b   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LOMUSTINE; METHOTREXATE; PREDNISOLONE; PROCARBAZINE; STEROID; VINCRISTINE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BLADDER DYSFUNCTION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG MEGADOSE; HAIR LOSS; HEADACHE; HUMAN; LEUKOENCEPHALOPATHY; MEMORY DISORDER; MUSCLE WEAKNESS; NEUROTOXICITY; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SEIZURE; VISUAL DISORDER;

EID: 20444424511     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20495     Document Type: Article

References (20)

1. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998;16:859-863.
2. Herrlinger U, Schabet M, Brugger W, et al. Primary CNS lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment. Cancer 2001;91:130-135.
3. Guha-Thakurta N, Darnek D, Pollack C, Hochberg FH. Intravenous methotrexate as initial treatment for primary CNS lymphoma: response to treatment and quality of life of patients. J Neurooncol 1999;43:259-268.
4. Herrlinger U, Brugger W, Bamberg M, et al. PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology 2000;54:1707-1708.
5. Herrlinger U, Schabet M, Brugger W, et al. German Cancer Society Neuro-Onoclogy Working Group NOA-03 multicenter trial of single agent high-dose methotrexate for primary CNS lymphoma. Ann Neurol 2002;51:247-252.
6. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-481.
7. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
8. Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-oncol 2000;2:221-228.
9. Fayers P, Aaronson N, Bjordal K. EORTC Scoring Manual. 2nd ed. Brussels, Belgium: EORTC Quality of Life Study Group, 1999.
10. Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003;21:1044-1049.
11. Glass JP, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphomas: long-term outcome. J Neurosurg 1994;81: 188-195.
12. Bessell EM, Graus F, Lopez-Guillermo A, et al. CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2001;50: 457-464.
13. DeAngelis LM, Seiferheld W, Schold SC, et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002;20:4643-4648.
14. O'Brien P, Roos D, Pratt G, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 2000;18:519-526.
15. Correa DD, DeAngelis LM, Shi W, et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62:548-555.
16. Harder H, Holtel H, Bromberg JE, et al. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 2004;62:544-547.
17. Meyers CA, Wefel JS. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 2003;21:3557-3558.
18. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000;18: 3144-3150.
19. Pels H, Schmidt-Wolf IG, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003;21:4489-4495.
20. Boiardi A, Silvani A, Pozzi A, Salmaggi A. Radiotherapy at tumor recurrence in primary CNS lymphoma. Neurology 1998; 50:1934-1935.